News / Strong Media Coverage Following the First TOUCH® Implantations in the United States

Strong Media Coverage Following the First TOUCH® Implantations in the United States

< 1 min

The first implantations of the TOUCH® CMC-1 prosthesis in the United States are generating growing interest both within the medical community and in the media.

Performed by Dr Jonathan Tueting (Rush Orthopaedics & Sports Medicine – Aurora), these initial procedures mark an important milestone in the introduction of carpometacarpal joint arthroplasty in the United States.

These first cases have already generated significant media coverage across the country, reflecting the increasing interest in thumb prostheses and their benefits for patients suffering from thumb arthritis.

Several media outlets — including hospitals, television channels and specialised orthopaedic publications — have recently reported on this development.

Florida Orthopaedic Institute – March 2026

A TV feature highlighting a “game-changing” technology for thumb arthritis, with Dr Devin Collins emphasising improvements in mobility, recovery and patient quality of life.

UC Health – February 2026

An institutional publication highlighting the benefits of thumb joint replacement for patients suffering from thumb arthritis.


CBS News Philadelphia – February 2026

A mainstream media outlet presenting the patient story and explaining the technology behind the implant.


Rush University Medical Center – January 2026

Rush Orthopaedics announced the first thumb joint replacement surgery performed in the United States using the TOUCH® CMC-1 prosthesis.



WGN Chicago – Medical Watch – January 2026

A major Chicago-based television channel featured the first US patient story and presented this innovative procedure.

Orthopedics This Week – September 2025

A leading orthopaedic publication highlighting the first implantation of the TOUCH® CMC prosthesis in the United States.


OrthoWorld – September 2025

An industry publication analysing the introduction of the TOUCH® prosthesis into the US market.